["In vitro" effects of erythromycin estearate on Shigella and enteropathogenic groups of Escherichia coli].
D003470:Culture Media; D004917:Erythromycin / Q000494:pharmacology*; D004926:Escherichia coli / Q000187:drug effects*; D004927:Escherichia coli Infections / Q000188:drug therapy; D006801:Humans; D066298:In Vitro Techniques; D007411:Intestinal Diseases, Parasitic / Q000188:drug therapy; D012762:Shigella dysenteriae / Q000187:drug effects*; D013229:Stearic Acids; D014776:Virus Cultivation
D003470:Culture Media; D013229:Stearic Acids; D004917:Erythromycin
Ação "in vitro" do estearato de eritromicina sôbre Shigella e grupos enteropatogênicos de Escherichia coli.